Showing results for "Category/Adult/Infectious diseases and Immune system"
Found 2 Clinical Trial s
This study intends to evaluate the safety and efficacy of ravulizumab for the treatment of COVID-19 severe pneumonia, acute lung injury or acute respiratory distress syndrome (ARDS).
This research study is looking at an experimental drug for patients who are in the hospital because of COVID-19. The goals of the study include seeing whether the drug lowers infection by the virus, whether it reduces the need to be in the hospital or the need to have breathing support, and whether ...